Sign In
Buy IGXT
$0.170
+0 (+0%)
At Close: Aug 26, 2025
IntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q4 2020 Results - Earnings Call Transcript
07:00pm, Thursday, 25'th Mar 2021
IntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q4 2020 Results - Earnings Call Transcript
IntelGenx Reports Fourth Quarter and Full-Year 2020 Financial Results
04:05pm, Thursday, 25'th Mar 2021
SAINT-LAURENT, Quebec, March 25, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the fourth quarter a
IntelGenx to Report Fourth Quarter and Full-Year 2020 Financial Results on March 25, 2021 – Conference Call to Follow
04:30pm, Thursday, 18'th Mar 2021
SAINT LAURENT, Quebec, March 18, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will release its fourth quarter and full-year
IntelGenx Files Provisional U.S. Patent Application for Novel VetaFilm™ High Loading Oral Film Platform
08:00am, Monday, 08'th Feb 2021
SAINT LAURENT, Quebec, Feb. 08, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it has filed a new provisional patent application at the United
IntelGenx Appoints Tommy Kenny as Vice President, Intellectual Property and Legal Affairs, General Counsel
04:15pm, Tuesday, 12'th Jan 2021
SAINT LAURENT, Quebec, Jan. 12, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (“IntelGenx” or the “Company”) today announced that its Board of Directors appoi
IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures
04:15pm, Wednesday, 06'th Jan 2021
SAINT LAURENT, Quebec, Jan. 06, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Corporation” or “IntelGenx”) announced that on December 31, 2020, it issue
IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures
08:15am, Tuesday, 08'th Dec 2020
SAINT-LAURENT, Quebec, Dec. 08, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces that it intends to issue 899,940 common
IntelGenx Grants Stock Options
05:00pm, Monday, 23'rd Nov 2020
SAINT-LAURENT, Quebec, Nov. 23, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. ("IntelGenx", or the “Company”) (TSX-V: IGX) (OTCQB:IGXT) announced today that the Company's board of director
IntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q3 2020 Results - Earnings Call Transcript
10:53pm, Thursday, 12'th Nov 2020
IntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q3 2020 Results - Earnings Call Transcript
IntelGenx Announces Issuance of U.S. Patent for Novel Technology Applicable to Cannabis-Containing Oral Films
08:30am, Wednesday, 11'th Nov 2020
SAINT LAURENT, Quebec, Nov. 11, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the United States Patent
IntelGenx Announces Publication of a Study Evaluating Montelukast's Effect on Neurological Aging
08:30am, Monday, 09'th Nov 2020
- Data Suggest Montelukast May Inhibit Mental Decline , Higher Doses Optimal for Clinical Trials Assessing Impact on Neurological Disease -
IntelGenx to Report Third Quarter 2020 Financial Results on November 12, 2020 – Conference Call to Follow
04:30pm, Thursday, 05'th Nov 2020
SAINT LAURENT, Quebec, Nov. 05, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will release its third quarter 2020 financial results after
IntelGenx Signs Letter of Intent with Heritage Cannabis for Long-Term Cannabis Filmstrip Supply Agreement
08:00am, Thursday, 29'th Oct 2020
SAINT LAURENT, Quebec, Oct. 29, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has executed a binding letter of intent (“LOI
